Bio-Tissue®, Inc. has reportedly entered a strategic collaboration agreement with Seattle-based eye bank SightLife™, were SightLife will provide Bio-Tissue’s cryopreserved amniotic membrane ocular wound healing products to hospitals and eye clinics in Kaiser Northern California, Southern California and the Pacific Northwest.
Through the agreement, SightLife will reportedly provide Kaiser facilities with Bio-Tissue’s AmnioGraft® biologic ocular transplantation graft, AmnioGuard® biologic glaucoma shunt tube graft, and PROKERA® biologic corneal bandage devices. According to Bio-Tissue, the collaboration will allow them to expand the use of their cryopreserved amniotic membrane products within Kaiser Permanente facilities.
Click here to read the full press release.